Today, the CCRA released its latest report on the investment in cancer research from 2005 to 2022, with a focus on the period 2020-2022 to examine the potential impact of COVID-19. There was $526M invested in cancer research in 2022. The overall cancer research inve... Read More »
Effective January 1st, 2024, CCRA welcomes Dr. Rosilene Kraft as the incoming patient/family representative on the CCRA Advisory Board. Most recently, Rosilene served on the 2023 PIP Working Committee and was cross-appointed to the conference Scientific Program Committee. Sh... Read More »